Starpharma Holdings have developed a gel to treat bacterial vaginosis.
Starpharma Holdings will manufacture a gel to treat bacterial
vaginosis.
The product called VivaGel , due to go for trials,
has an antimicrobial agent which can hinder the growth of bacteria . The gel
does not cause any side-effects.
About Bacterial Vaginosis Bacterial vaginosis (BV) is a disorder characterized by an offensive vaginal discharge & it is most common among women of childbearing age.
Going by the number of responses from people
interested in trials, the company expects to begin product trial very soon and
complete it within 8-12 weeks.
Source-Medindia
About Vaginitis Vaginal infection or vaginitis occurs due to an overgrowth of bacteria or yeast or trichomoniasis and is aggravated by chemicals, like soap and deodorants
Bacterial Vaginosis Increases HIV Risk: Study Researchers at the University of North Carolina at Chapel Hill School of Public Health have found that a common vaginal infection may make women more susceptible to contracting HIV,